PARIS, Dec 6 - French pharmaceuticals group Ipsen set the price for its initial public offering at 22.20 euros, near the low-end of its indicative price range and valuing the company at 1.84 billion euros, before a greenshoe option, stock market operator Euronext said on Tuesday.